The condition is “high-risk” plaque, once narrowly defined as plaque built up in the arteries that is likely to rupture, possibly leading to an acute heart attack or sudden cardiac death.

Chinese researchers say they have developed a “cocktail” nanovaccine to prevent plaque from building up in the arteries – an underlying factor in heart disease, which is the leading cause of ...